The University of Chicago Header Logo

Connection

Ardaman Shergill to HLA Antigens

Back to Details
This is a "connection" page, showing publications Ardaman Shergill has written about HLA Antigens.
Ardaman Shergill
Connection Strength
0.053
HLA Antigens
  1. A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nat Med. 2024 Apr; 30(4):1013-1022.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.